RNA Analysis/ Transcriptomics Market worth $3,773.0 Million by 2019 New Report by MarketsandMarkets
(PRWEB) November 06, 2014 -- The report is "RNA Analysis Market by Technology, by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019".
Browse 217 Market Data Tables, 20 Figures and 30 Pages and in-depth TOC on "RNA Analysis Market"
http://www.marketsandmarkets.com/Market-Reports/trancriptomics-market-240344576.html
Early buyers will receive 10% customization on this report.
The global Transcriptomics Market is estimated to be worth $1985.5 million by the end of 2014 and is expected to reach $3,773.0 million by 2019, at a CAGR of 13.7% from 2014 to 2019.
The global market covers transcriptomic technologies, applications, and end-users. The RNA Analysis technologies market is segmented as microarray, PCR, sequencing technologies which include Sanger sequencing and NGS, and RNAi gene silencing technology.
Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=240344576
Technological advancements, increasing investments in research and development, Increasing government and private funding, and growing preference for personalized medicines are some of the major factors driving the growth of this market. However, the market also faces certain challenges in terms of high capital investment costs that limit the adoption of transcriptomics products, lack of skilled professionals and effective bioinformatics tools for data analysis. These challenges may hamper the growth of the transcriptomics market in the coming years.
Based on utilization of advanced technology, PCR accounted for more than 45.3% of the global transcriptomics market in 2013. However, sequencing technologies market is expected to grow at the highest CAGR of 14.3% during the forecast period of 2014 to 2019. A majority of the growth in this segment is attributed to rising demand for these technologies from academic research and government institutes. Increasing application of transcriptomics in drug discovery is driving the demand for transcriptomic technologies in the pharmaceutical and biotechnology industry. Based on the type of product, the reagents account for the largest share of approximately 53.6% of the global transcriptomics market in 2013. Transcriptomic instruments are priced higher than the reagents. However, frequent purchase of consumables including reagents has led to its greater market share and robust growth rate during the forecast period.
Speak to Research Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=240344576
There is an extensive use of transcriptomics in the academic research and government institutes which account for highest share of 49.2% of the transcriptomics market for various research applications followed by pharmaceutical and biotechnology companies. Similarly, the drug discovery and research contributes major share of x64.1% to the total market followed by clinical diagnostics with 28.6% share of the global market. However, the pharmaceutical and biotechnology companies, and clinical diagnostics segment are expected to grow at a higher CAGR during the forecast period.
The prominent players in the market are Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.).
Browse related report
Nucleic Acid Isolation and Purification Market by Technology (Column based, Reagent based, Magnetic bead based), Consumables & Instruments, Application (Plasmid DNA isolation, MIRNA isolation, Total RNA isolation) & by End Users - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-purification-market-229978287.html
Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, healthcare IT semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Mr. Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article